| Trial ID: | L5750 |
| Source ID: | NCT04355832
|
| Associated Drug: |
Glucagon-Like Peptide-1
|
| Title: |
Glucagon-like Peptide-1 in Type 1 Diabetes
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type1 Diabetes Mellitus
|
| Interventions: |
DRUG: Glucagon-like peptide-1|DRUG: Placebos
|
| Outcome Measures: |
Primary: Change in the level of catecholamines in plasma, 3 years |
|
| Sponsor/Collaborators: |
Sponsor: University of Maryland, Baltimore
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: OTHER
|
| Start Date: |
2020-06-24
|
| Completion Date: |
2026-09
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-05
|
| Locations: |
University of Maryland, Baltimore, Maryland, 21201, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT04355832
|
